Advertisement

  • Loading metrics

Open Access

Correction

Correction: Rational Development of an Attenuated Recombinant Cyprinid Herpesvirus 3 Vaccine Using Prokaryotic Mutagenesis and In Vivo Bioluminescent Imaging

  • The PLOS Pathogens Staff
  • Article
  • Metrics
  • Comments
  • Media Coverage

Notice of Republication

This article was republished on April 6, 2015, to correct errors that were introduced during the typesetting process. Fig 4 was incorrectly cropped, and we have also corrected some typographical errors in the text. The publisher apologizes for these errors. Please download this article again to view the correct version. The originally published, uncorrected article and the republished, corrected article are provided here for reference.

Supporting Information

S1 File. Originally published, uncorrected article.

https://doi.org/10.1371/journal.ppat.1004861.s001

(PDF)

S2 File. Republished, corrected article.

https://doi.org/10.1371/journal.ppat.1004861.s002

(PDF)

Reference

  1. 1. Boutier M, Ronsmans M, Ouyang P, Fournier G, Reschner A, Rakus K, et al. (2015) Rational Development of an Attenuated Recombinant Cyprinid Herpesvirus 3 Vaccine Using Prokaryotic Mutagenesis and In Vivo Bioluminescent Imaging. PLoS Pathog 11(2): e1004690. pmid:25700279

Citation: The PLOS Pathogens Staff (2015) Correction: Rational Development of an Attenuated Recombinant Cyprinid Herpesvirus 3 Vaccine Using Prokaryotic Mutagenesis and In Vivo Bioluminescent Imaging. PLoS Pathog 11(4): e1004861. https://doi.org/10.1371/journal.ppat.1004861

Published: April 22, 2015

Copyright: © 2015 The PLOS Pathogens Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited